Morning Market Losers

Revance Therapeutics

RVNC

shares dipped 28.33% to $15.05 after the company reported a Q3 net loss of $14.0 million, versus a year-ago loss of $8.9 million. Local

LOCM

shares fell 24.63% to $1.30 after the company reported a Q3 loss of $0.06 per share on revenue of $18.10 million and issued a weak sales forecast. La Jolla Pharmaceutical Co

LJPC

dropped 11.04% to $11.69 after the company reported a Q3 loss of $0.37 per share and reported that primary endpoint for Phase 2 trial of GCS-100 was met. SunPower

SPWR

Pre-IPO Offer: Get A Piece Of A Nearly $5T Global Opportunity By Joining BOXABL As An Early Shareholder At Just $0.80/Share

Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.

Share Price: $0.80

Min. Investment: $1,000

Valuation: $3.5B

tumbled 7.53% to $26.95 after the company issued FY15 guidance. For fiscal year 2015, the company expected net income per diluted share of $1.10 to $1.50 on non-GAAP revenue of $2.4 billion to $2.6 billion. J. C. Penney Company

JCP

shares slipped 9.54% to $7.02 after the company reported a narrower-than-expected third-quarter loss, but its sales were slightly below the Wall Street consensus. The company also posted flat same-store sales in the quarter. Regulus Therapeutics

RGLS

shares tumbled 9.49% to $17.76 after falling 4.15% on Wednesday. Texas Capital BancShares

TCBI

slipped 3.14% to $59.80 after the company priced 2.5 million common stock offering. Kohl's

KSS

dipped 2.02% to $56.74 after the company reported weaker-than-expected fiscal third-quarter profit.